Bilfinger Berger wins €30m deal for work on Genzyme plant
Bilfinger Berger has won a €30m ($43m) contract to help Genzyme add 8,000L of production capacity at its site in Geel, Belgium.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs